We are pleased to inform you that the first trial participant was enrolled at the Hospital of Neuchâtel on 22nd of December 2022. Thank you for your great effort!

First patient enrolled in Zwolle!

We are pleased to inform you that the first trial participant was enrolled at the Isala Klinieken in Zwolle (NL) on 29th of November 2022. Thank you for your great effort!

The Albert Schweitzer Ziekenhuis (ASZ) in Dordrecht has enrolled the first study participant

We are pleased to inform that the Albert Schweitzer Ziekenhuis (ASZ) in Dordrecht has enrolled the first study participant on 9th of August 2022. Until today the ASZ enrolled 3 study participants. Thank you for your great effort!

A new site in the Netherlands, the Isala Klinieken in Zwolle, was initiated and started with patient recruiting.

We are happy to inform you that the fourth Dutch site, the Isala Klinieken in Zwolle, could be opened for patient recruitment. We wish the study team good luck!

The Ottawa Hospital in Canada open for accrual!

We are happy to inform you that the Ottawa Hospital in Canada is now open for accrual. We wish the team in Ottawa good luck!

A new site in the Netherlands, the Albert Schweitzer Ziekenhuis in Dordrecht, was initiated and started with patient recruiting.

We are happy to anounce that the third site, the Albert Schweitzer Ziekenhuis in Dordrecht, started with patient recruitment. We wish you all good luck for patient recruiting!

First patient enrolled at the Cantonal Hospital of Baden!

We are pleased to inform that the first trial participant was enrolled at the Cantonal Hospital in Baden on 21st of January 2022. Thank you for your great effort!

A new site in the Netherlands, the Erasmus University Medical Center in Rotterdam, was initiated and started with patient recruiting.

We are happy to anounce that the Erasmus University Medical Center in Rotterdam started with patient recruitment. We wish you all good luck!